Sign in

CIK 0001699031 · Non-accelerated filer<br>Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863673636
Phone
(833) 694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
  1. 4 Open-market sale Chief Executive Officer sold 7,239 shares at $68.88 ($498,622)
  2. 4 Grant or award Director acquired 267 shares (grant or award)
  3. 4 Planned sale President sold 14,979 shares at an average $78.47 ($1,175,394)
  4. 4 Grant or award Director acquired 425 shares (grant or award)
  5. 4 Grant or award Director acquired 275 shares (grant or award)
  6. 4 Open-market sale President sold 81,385 shares at $62.50 ($5,086,563)
  7. 4 Planned sale President sold 9,692 shares at $64.00 ($620,312)
  8. 4 Open-market sale President sold 4,202 shares at $32.02 ($134,548)
  9. 4 Open-market sale Chief Financial Officer sold 877 shares at $32.02 ($28,082)
  10. 4 Grant or award Director acquired 533 shares (grant or award)
  11. 4 Grant or award Director acquired 825 shares (grant or award)
  12. 4 Grant or award Director acquired 517 shares (grant or award)
  13. 4 Planned sale Chief Financial Officer sold 8,000 shares at $38.93 ($311,440)
  14. 4 Open-market sale 10% owner sold 339,800 shares at an average $49.53 ($16,830,151)
  15. 4 Planned sale President sold 9,692 shares at $52.00 ($503,984)
  16. 4 Planned sale President sold 9,692 shares at $42.30 ($410,019)
  17. 4 Grant or award Director acquired 6,082 shares (grant or award)
  18. 4 Grant or award Director acquired 6,082 shares (grant or award)
  19. 4 Grant or award Director acquired 6,082 shares (grant or award)
  20. 4 Grant or award Director acquired 6,082 shares (grant or award)

Page 3 of 6 · 115 filings